In order to guarantee that innovative tuberculosis (TB) vaccines reach adults and adolescents in high-burden nations, a new WHO report that was released on the fringes of the G20 Health Ministers Meeting in Limpopo, South Africa, argues for daring
Marksans Pharma Limited has announced that its wholly owned subsidiary in the United Kingdom, Relonchem Limited, has obtained Marketing Authorization from the UK Medicines and Healthcare products Regulatory Agency (MHRA) for its product Exemestane 2
Ahmedabad-based Intas Pharmaceuticals has reinforced its position as a leading player in the Indian Pharmaceutical Market (IPM), maintaining the 6th rank for both September 2025 and the Moving Annual Turnover (MAT) period. The company reported...
India pharmaceutical industry is going next-generation cell and gene therapy decisively, inspiring cancer treatment accessibility at a lower cost.
Novo Holdings, the controlling shareholder of obesity drugmaker Novo Nordisk, is stepping up its focus on India’s fast-growing healthcare sector, eyeing investments in single-specialty hospitals and contract drug manufacturing...
JB Chemicals and Pharmaceuticals, along with USV, are conducting a voluntary recall of antihistamine medications in the United States.
The Subject Expert Committee (SEC) which is under the Central Drugs Standard Control Organization (CDSCO) has given the green signal to AstraZeneca India Pharma Limited’s application of Sodium Zirconium Cyclosilicate
Akums Drugs and Pharmaceuticals has made a major landmark by receiving a 20-year patent for its revolutionary 'tablet-in-tablet' technology aimed at treating Gastroesophageal Reflux Disease (GERD).
MedGenome, a leading global genomics-based diagnostics and research company, has made a majority investment in Gujarat-headquartered Green Cross Genetics Lab, strengthening its footprint in India’s growing diagnostics market...
Amgen has declared that new findings from its cardiovascular portfolio, which includes late-breaking results from the phase 3 VESALIUS-CV clinical trial of Repatha (evolocumab), will be showcased at the American Heart Association (AHA) Scientific
.jpg)
, CDSCO.jpg)